Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin
Investors
Media Coverage
NASDAQ: ENVB
Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Media Coverage
The Future Of MDMA-Assisted Therapy After FDA Rejection — Where Do We Go Now? [Clinical Leader]
August 16, 2024
FDA Rejects MDMA-Assisted PTSD Therapy [Psychiatrist.com]
August 14, 2024
FDA Rejected MDMA-Assisted PTSD Therapy: Psychedelic Industry Responds [Microdose]
August 14, 2024
Enveric Biosciences Announces Promising Preclinical Results for EB-003 [Microdose]
July 25, 2024
Non-Hallucinogenic Psychedelic Treatment For Mental Health Disorders Shows Potential To Be Dosed Orally [Benzinga]
July 25, 2024
BUSINESSPUBLIC Enveric bets on trip-free mental health drug for FDA approval hopes [Green Market Report]
June 25, 2024
Psychedelic Community Reacts To FDA Committee’s Critique Of Lykos’ MDMA Studies [Clinical Leader]
June 14, 2024
Psychedelics companies see FDA panel’s vote as a growth opportunity, not a roadblock [Stat News]
June 6, 2024
Enveric, MindBio partner to advance psilocin prodrugs for mental health disorders [Healio]
May 21, 2024
Rx Rundown: Sanofi, Bayer, Sands Capital and more [MMM]
May 17, 2024
1
2
3
…
11
›
Close Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
